The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Toxicity and efficacy of busulfan-melphalan (BuMel) compared to treosulfan-melphalan (TreoMel) high dose chemotherapy (HDCT) consolidation in high-risk Ewing sarcoma (ES): A 12-year monoinstitutional experience.
 
Massimo Eraldo Abate
No Relationships to Disclose
 
Anna Paioli
No Relationships to Disclose
 
Marilena Cesari
No Relationships to Disclose
 
Alessandra Longhi
No Relationships to Disclose
 
Emanuela Palmerini
Honoraria - Amgen
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Lilly
Research Funding - Daiichi Sankyo; PharmaMar (Inst)
Travel, Accommodations, Expenses - Amgen; Lilly; Takeda
 
Elisabetta Setola
No Relationships to Disclose
 
Elisa Carretta
No Relationships to Disclose
 
Silvia Cammelli
No Relationships to Disclose
 
Letizia Ronchi
No Relationships to Disclose
 
Michele Rocca
No Relationships to Disclose
 
Marco Manfrini
No Relationships to Disclose
 
Katia Scotlandi
No Relationships to Disclose
 
Davide Maria Donati
No Relationships to Disclose